AI Article Synopsis
- Ductal adenocarcinoma represents 85-90% of pancreatic cancers, is on the rise, and is the fourth leading cause of cancer deaths, with no current screening tests available.
- Surgery is the only potential cure for pancreatic adenocarcinoma, while imaging plays a vital role in detecting tumors, assessing treatment response, and determining surgical feasibility.
- Pancreatic neuroendocrine neoplasms have unique imaging characteristics that are important for proper diagnosis and management of affected patients.
Article Abstract
Ductal adenocarcinoma accounts for 85% to 90% of all solid pancreatic neoplasms, is increasing in incidence, and is the fourth leading cause of cancer-related deaths. There are currently no screening tests available for the detection of ductal adenocarcinoma. The only chance for cure in pancreatic adenocarcinoma is surgery. Imaging has a crucial role in the identification of the primary tumor, vascular variants, identification of metastases, disease response assessment to treatment, and prediction of respectability. Pancreatic neuroendocrine neoplasms can have a distinctive appearance and pattern of spread, which should be recognized on imaging for appropriate management of these patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.soc.2014.07.002 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!